Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients

NCT01189409 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

70

Enrollment

OTHER

Sponsor class

Stopped This study was terminated based on results of interim analysis.

Conditions

Constipation
Cancer

Interventions

DRUG: PEG then Senna
DRUG: Senna then PEG

Sponsor

British Columbia Cancer Agency